Edge
StocktwitsEarnings

Official STOCKTWITS Representative
$IOVA Q2 '26 Earnings Results & Recap
• Reported GAAP EPS of -$0.11 up 66.67% YoY
• Reported revenue of $198.63M up 231.31% YoY
• Iovance Biotherapeutics is reviewing its previously issued 2026 total revenue guidance of $350 million to $370 million based on strong second-quarter sales and current demand trends, with an update expected later.1
2
43
